INSERM Limoges

What INSERM Limoges does

INSERM Limoges is a private, for-profit French entity classified under the activité code "recherche-développement en autres sciences physiques et naturelles," indicating a research and development orientation in physical and natural sciences. The firm was founded in 2018 and currently reports a headcount of 51-100 employees, suggesting a small-to-mid-sized operating team consistent with a research-stage organization. Its public web presence, listed at inserm.fr/en/, returned only a loading/verification page during data collection, providing no additional substantive information on operations, management, or output.

No products, services, pricing model, go-to-motion, customer segments, partnerships, awards, patents, or management team are disclosed in the input data. The ownership commentary explicitly states that ownership structure, key stakeholders, and control relationships cannot be determined from the available content. Similarly, no revenue, funding history, geographic footprint, or regulatory actions are documented. As a result, the business model, revenue mechanics, and customer profile are not assessable from the evidence provided, and any investment-relevant inferences beyond the firmographic anchor (R&D entity, ~51-100 employees, founded 2018) would be unsupported.

The name references the broader INSERM (Institut national de la santé et de la recherche médicale) brand, a major French public health research institution; however, the input treats INSERM Limoges as a discrete private for-profit entity rather than a confirmed subsidiary or unit of the public institute. This relationship is unverified in the source data and should be treated as an open question.

Name

INSERM Limoges

Website

https://inserm.fr

Company type

Private

Founded year

2018

Headcount range

51–100 employees

Short description

INSERM Limoges is a private, for-profit French research and development entity operating in the physical and natural sciences, founded in 2018 with 51-100 employees. Its specific products, customers, and revenue model are not disclosed in available sources.

Ownership category

akta.pro rank

Product category

Research and Development Services

NAICS

Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro industry

PRIMARYHLAGAOAG

Medical Affairs, Scientific Communications & HEOR FSP

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)

SECONDARYBPACADAL

Life Sciences & Biotech (R&D/Clinical) Staffing

Business & Public Services/HR, Staffing & Recruitment Services/Professional & Technical Staffing (IT/Engineering/Healthcare/Finance)

Keywords

• Scientific research services
• Biomedical research
• Physical sciences R&D
• Natural sciences research
• Health research laboratory

Headquarters

HQ city

Paris

HQ country

France

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure

Core offering

INSERM Limoges performs research and development activities in physical and natural sciences, operating as a private, for-profit entity founded in 2018 with 51-100 employees. The organization delivers scientific R&D services aligned with the broader INSERM health and medical research framework, supporting laboratory-based scientific investigation. Specific deliverable products, service tiers, and customer-facing offerings are not documented in the available source data.

Differentiator

Problem solved

Functional benefit

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Expansion highlights1 record

Broad incumbents

• CEA (Commissariat à l'énergie atomique et aux énergies alternatives): French public research organization with missions spanning energy, health and life sciences R&D. Comparable in operating model and capacity to run publicly funded scientific programs in life and physical sciences.
• INRAE (Institut national de recherche pour l'agriculture, l'alimentation et l'environnement): Another large French public R&D institute with life- and physical-sciences mandates. Comparable in governance (mixed research units hosted in universities) and ability to deliver translational scientific programs.
• CNRS (Centre national de la recherche scientifique): France's largest public basic-research organization covering physical, engineering and life sciences. Comparable public-mission R&D scale and academic-style operating model relevant to a Limoges-based research unit.
• Institut Pasteur: Major French biomedical research foundation. Relevant as a comparable French life-sciences research body with multi-site footprint and international partnership channels.
• INSERM (national headquarters): The parent French national institute for health and medical research. Limoges operates as a regional unit within this broader public research organization, sharing mission, governance and funding channels.

Regional players

• Université de Limoges: Local university partner that commonly co-hosts INSERM research units in joint laboratories. Comparable as the academic counterpart within the same Limoges research ecosystem.
• EFS (Établissement français du sang): French national public health operator conducting biomedical and transfusion-related research. Comparable as a publicly funded France-based life-sciences research and service entity.
• University Hospital Center of Limoges (CHU Limoges): The teaching hospital in Limoges that typically hosts INSERM mixed research units. Functions as a co-located clinical-research counterpart and shares investigators, samples and clinical infrastructure with an INSERM Limoges entity.

Market position

Strengths2 records

Weaknesses2 records

Competitive moat2 records

Key highlights3 records

Customer concentration

• LinkedInlinkedin.com/company/universit-de-limoges

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about INSERM Limoges